PortfoliosLab logoPortfoliosLab logo
PRCT vs. SGMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PRCT vs. SGMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PROCEPT BioRobotics Corporation (PRCT) and Sagimet Biosciences Inc. (SGMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PRCT achieves a -34.52% return, which is significantly lower than SGMT's 19.93% return.


PRCT

1D
-2.18%
1M
-28.97%
YTD
-34.52%
6M
-37.04%
1Y
-64.93%
3Y*
-14.75%
5Y*
10Y*

SGMT

1D
6.29%
1M
0.14%
YTD
19.93%
6M
13.78%
1Y
-18.58%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PRCT vs. SGMT - Yearly Performance Comparison


2026 (YTD)202520242023
PRCT
PROCEPT BioRobotics Corporation
-34.52%-60.93%92.13%11.82%
SGMT
Sagimet Biosciences Inc.
19.93%31.56%-16.97%-65.03%

Correlation

The correlation between PRCT and SGMT is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Jul 14, 2023

0.20

Fundamentals

EPS

PRCT:

-$2.46

SGMT:

-$1.34

Total Revenue (TTM)

PRCT:

$322.02M

SGMT:

$0.00

Gross Profit (TTM)

PRCT:

$206.01M

SGMT:

$0.00

EBITDA (TTM)

PRCT:

-$90.33M

SGMT:

-$48.74M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PRCT vs. SGMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRCT
PRCT Risk / Return Rank: 55
Overall Rank
PRCT Sharpe Ratio Rank: 44
Sharpe Ratio Rank
PRCT Sortino Ratio Rank: 33
Sortino Ratio Rank
PRCT Omega Ratio Rank: 55
Omega Ratio Rank
PRCT Calmar Ratio Rank: 22
Calmar Ratio Rank
PRCT Martin Ratio Rank: 99
Martin Ratio Rank

SGMT
SGMT Risk / Return Rank: 3535
Overall Rank
SGMT Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
SGMT Sortino Ratio Rank: 3939
Sortino Ratio Rank
SGMT Omega Ratio Rank: 3838
Omega Ratio Rank
SGMT Calmar Ratio Rank: 3131
Calmar Ratio Rank
SGMT Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PRCT vs. SGMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Sagimet Biosciences Inc. (SGMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PRCTSGMTDifference
Sharpe ratioReturn per unit of total volatility

-0.85

Sortino ratioReturn per unit of downside risk

-2.24

Omega ratioGain probability vs. loss probability

0.79

1.04

-0.25

Calmar ratioReturn relative to maximum drawdown

-0.99

-0.34

-0.66

Martin ratioReturn relative to average drawdown

-1.40

-0.54

-0.85

PRCT vs. SGMT - Sharpe Ratio Comparison

The current PRCT Sharpe Ratio is -1.06, which is lower than the SGMT Sharpe Ratio of -0.21. The chart below compares the historical Sharpe Ratios of PRCT and SGMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PRCT vs. SGMT - Drawdown Comparison

The maximum PRCT drawdown since its inception was -79.29%, smaller than the maximum SGMT drawdown of -89.69%. Use the drawdown chart below to compare losses from any high point for PRCT and SGMT.


Loading charts...

Drawdown Indicators


PRCTSGMTDifference

Max Drawdown

Largest peak-to-trough decline

-79.29%

-89.69%

+10.40%

Max Drawdown (1Y)

Largest decline over 1 year

-65.70%

-55.57%

-10.13%

Max Drawdown (3Y)

Largest decline over 3 years

-79.29%

Current Drawdown

Current decline from peak

-79.29%

-61.45%

-17.84%

Average Drawdown

Average peak-to-trough decline

-32.11%

-65.84%

+33.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.45%

34.22%

+12.23%

Volatility

PRCT vs. SGMT - Volatility Comparison

PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 19.09% compared to Sagimet Biosciences Inc. (SGMT) at 13.31%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than SGMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PRCTSGMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.09%

13.31%

+5.78%

Volatility (6M)

Calculated over the trailing 6-month period

48.21%

60.00%

-11.79%

Volatility (1Y)

Calculated over the trailing 1-year period

61.33%

88.89%

-27.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

65.55%

150.51%

-84.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

65.55%

150.51%

-84.96%

Dividends

PRCT vs. SGMT - Dividend Comparison

Neither PRCT nor SGMT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PRCT vs. SGMT - Financials Comparison

This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Sagimet Biosciences Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M20222023202420252026
83.13M
0
(PRCT) Total Revenue
(SGMT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PRCT and SGMT have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PRCT has higher volatility (19.09%) compared to SGMT (13.31%). In terms of maximum drawdown, PRCT dropped -79.29% vs SGMT's -89.69%.

SGMT currently has the higher Sharpe Ratio (-0.21 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PRCT and SGMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer